Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
Top Beauty and Cosmetics Stocks That May Drive Long-Term Growth
09:21am, Wednesday, 16'th Jul 2025
EL, COTY and ULTA are tapping AI, e-commerce, and clean beauty to ride the next wave of long-term industry growth.
J&J CFO Joseph Wok on Q2 results: 2025 is shaping up to be better than what we'd thought
07:27am, Wednesday, 16'th Jul 2025
Johnson & Johnson executive vice president and CFO Joseph Wolk joins 'Squawk Box' to discuss the company's quarterly earnings results, raising FY guidance, drug pipeline outlook, and more.
Johnson & Johnson Tops Q2 Estimates, Lifts Outlook for Sales and Profit
07:20am, Wednesday, 16'th Jul 2025
Johnson & Johnson (JNJ) on Wednesday lifted its full-year projections and reported second quarter results that beat estimates.
3 Magnificent S&P 500 Dividend Stocks Down 16% to 20% to Buy and Hold Forever
07:12am, Wednesday, 16'th Jul 2025
If you look at the history of the S&P 500 (^GSPC -0.40%) index, dividend stocks have played a significant role in shareholder returns. Over the past 25 years, for example, while the S&P 500 rose over
Johnson & Johnson (NYSE: JNJ) Live Earnings Updates: Will The Dividend Champion Deliver?
07:05am, Wednesday, 16'th Jul 2025
Johnson & Johnson reports before the bell today. The stock is popular in part thanks to its 3.3% dividend yield.
Johnson & Johnson's stock rallies after earnings beat and outlook raised, amid strength in heart and cancer treatments
06:28am, Wednesday, 16'th Jul 2025
Shares of Johnson & Johnson JNJ-1.05% climbed 1.6% in premarket trading Wednesday, after the drugmaker beat second-quarter earnings expectations and raised its full-year outlook, amid strength in sale
Johnson & Johnson beats profit estimates on strong Darzalex, medtech sales
06:27am, Wednesday, 16'th Jul 2025
Johnson & Johnson reported second-quarter profit and raised its full-year sales forecast by around $2 billion on Wednesday as strong demand for its cancer drug, Darzalex, and strength in its medical d
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2025
06:25am, Wednesday, 16'th Jul 2025
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the third quarter of 2025 of $1.30 per share on the com
Johnson & Johnson Reports Q2 2025 Results; Raises 2025 Outlook
06:20am, Wednesday, 16'th Jul 2025
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced results for second-quarter 2025. “Today's strong results reflect the depth and strength of Johnson & Johnson's uni
3 Medical Stocks to Watch as Q2 Earnings Approach: ABT, JNJ, NVS
05:56pm, Tuesday, 15'th Jul 2025
The broader market's historic rebound may make it necessary to consider some defensive positions in the portfolio, and these medical stocks fit the bill ahead of their Q2 reports.
10 Dividend Stocks to Double Up On Right Now
05:08am, Tuesday, 15'th Jul 2025
Dividend stocks can make great long-term investments. They've outperformed nonpayers by more than 2-to-1 over the past 50 years, with a 9.2% average annual return compared with 4.3%, according to data
Should You Buy Johnson & Johnson Stock Before July 16th?
03:00am, Tuesday, 15'th Jul 2025
Johnson & Johnson (JNJ 0.01%) has been a leading healthcare company in the world for decades, and it's one of the most valuable as well, with a market cap of around $380 billion. Known for its long-te
These 3 Undervalued Stocks Could Surge as Value Rotation Nears
05:09pm, Monday, 14'th Jul 2025
One of the most reliable gauges of sentiment in the stock market is where growth stocks trade relative to value stocks, since any given extreme can signal above-average optimism or pessimism, creating
Pre-Markets in the Red to Start a Fresh Week
12:05pm, Monday, 14'th Jul 2025
Pre-market futures are notably lower than Friday afternoon's close on all major indexes, though they are beginning to climb out of the muck of fresh tariff threats as early trading warms up to start a
Andrew Hill Dumps 38,000 Johnson & Johnson Shares in Q2 2025 Exit
11:54am, Monday, 14'th Jul 2025
On July 11, 2025, Andrew Hill Investment Advisors, Inc. disclosed it sold out its entire Johnson & Johnson (JNJ -0.63%) position, totaling $6.31 million in trades.
